GSK plc
New York Stock ExchangeTotal Valuation
GSK plc carries a market capitalization of 99.99B, placing it among publicly traded companies globally. Its enterprise value stands at 99.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 99.99B |
| Enterprise Value | 99.42B |
Share Statistics
GSK plc currently has 4.02B shares outstanding.
| Shares Outstanding | 4.02B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
GSK plc trades at a trailing price-to-earnings ratio of 14.45. The price-to-sales ratio is 2.57, and the price-to-book ratio stands at 6.51.
| PE Ratio | 14.45 |
| PS Ratio | 2.57 |
| PB Ratio | 6.51 |
| P/TBV Ratio | -10.53 |
| P/FCF Ratio | 7.97 |
| P/OCF Ratio | 10.89 |
Enterprise Valuation
On an enterprise value basis, GSK plc trades at an EV/EBITDA multiple of 11.81 and an EV/FCF ratio of 8.79. The EV/Sales ratio of 3.03 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.81 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.03 |
| EV / EBITDA | 11.81 |
| EV / EBIT | 11.81 |
| EV / FCF | 8.79 |
Financial Position
GSK plc maintains a current ratio of 0.79, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 109.38, indicating elevated leverage, while an interest coverage ratio of 12.16 demonstrates strong ability to service its debt obligations.
| Current Ratio | 0.79 |
| Quick Ratio | 0.15 |
| Debt / Equity | 109.38 |
| Debt / EBITDA | 2.26 |
| Interest Coverage | 12.16 |
Financial Efficiency
GSK plc posts a return on equity of 51.60 and a return on invested capital of 20.62.
| Return on Equity (ROE) | 51.60 |
| Return on Assets (ROA) | 9.43 |
| Return on Invested Capital (ROIC) | 20.62 |
| Return on Capital Employed (ROCE) | 19.93 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.47 |
Taxes
Over the trailing twelve months, GSK plc has paid 1.08B in income taxes, reflecting an effective tax rate of 14.54.
| Income Tax | 1.08B |
| Effective Tax Rate | 14.54 |
Stock Price Statistics
GSK plc's stock has gained approximately 21.86275% over the past 52 weeks. The 50-day moving average sits at 53.47, while the 200-day moving average is 49.37.
| Beta (5Y) | N/A |
| 52-Week Price Change | 21.86275% |
| 50-Day Moving Average | 53.47 |
| 200-Day Moving Average | 49.37 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, GSK plc generated 32.78B in revenue and converted that into 5.83B in net income, yielding earnings per share of 3.11. EBITDA reached 8.42B, while operating income came in at 8.42B.
| Revenue | 32.78B |
| Gross Profit | 23.83B |
| Operating Income | 8.42B |
| Pretax Income | 7.44B |
| Net Income | 5.83B |
| EBITDA | 8.42B |
| EBIT | 8.42B |
| Earnings Per Share (EPS) | 3.11 |
Balance Sheet
GSK plc holds 3.44B in cash and equivalents against 19.06B in total debt, resulting in a net debt position of -3.44B. Total book value stands at 12.94B, with working capital of -4.67B providing operational flexibility.
| Cash & Cash Equivalents | 3.44B |
| Total Debt | 19.06B |
| Net Debt | -3.44B |
| Equity (Book Value) | 12.94B |
| Book Value Per Share | 6.41 |
| Working Capital | -4.67B |
Cash Flow
GSK plc produced 7.74B in operating cash flow over the past twelve months. After subtracting -2.98B in capital expenditures, free cash flow totaled 4.76B - equivalent to 2.36 per share.
| Operating Cash Flow | 7.74B |
| Capital Expenditures | -2.98B |
| Free Cash Flow | 4.76B |
| FCF Per Share | 2.36 |
Margins
GSK plc operates with a gross margin of 72.68, reflecting its pricing power and cost economics. The operating margin of 25.67 and net profit margin of 17.78 provide insight into operational efficiency.
| Gross Margin | 72.68 |
| Operating Margin | 25.67 |
| Pretax Margin | 22.69 |
| Profit Margin | 17.78 |
| EBITDA Margin | 25.67 |
Dividends & Yields
The company's payout ratio of 37.70 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.29 |
| Dividend Yield | N/A |
| Payout Ratio | 37.70 |
| Shareholder Yield | 5.07 |
| FCF Yield | 12.54 |
Stock Splits
GSK plc's most recent stock split took place on July 22, 2022 with a 5:4 split ratio.
| Last Split Date | 7/22/2022 |
| Split Ratio | 5:4 |
Scores
GSK plc posts an Altman Z-Score of 3.01, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.01 |